|
| Selection evaluation of Xuebijing Injection by the Experts Consensus on the Selection of Chinese Patent Medicine in Medical Institutions |
| Hits 570 Download times 357 Received:August 19, 2023 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2023.12.13 |
| Key Words
Xuebijing Injection;Experts Consensus on the Selection of Chinese Patent Medicine in Medical Institutions;drug selection;Chinese patent medicine;selection evaluation |
| Author Name | Affiliation | | JU Xiaoyu | Department of Pharmacy, Hebei Province Hospital of TCM, Shijiazhuang 050011, China | | ZHAO Yue | Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050054, China | | CHENG Jie | Department of Pharmacy, Hebei Province Hospital of TCM, Shijiazhuang 050011, China |
|
| Abstract
|
| [Objective] To provide objective and accurate suggestions for the selection and rational use of Chinese patent medicines in medical institutions by carrying out the multi-dimensional evaluation of Xuebijing Injection. [Methods] According to the Expert Consensus on the Selection of Chinese Patent Drugs in Medical Institutions,Xuebijing Injection was comprehensively and systematically evaluated. [Results] The total score of Xuebijing injection is 71.0 points,including 19.0 points for safety,17.5 points for effectiveness,7.0 points for economy,8.0 points for innovation,4.5 points for suitability,7.0 points for accessibility and 8.0 points for inheritance. In terms of effectiveness,Xuebijing's clinical indications are irreplaceable,filling the gap in the treatment of sepsis and serving as the only injection among the “three drugs and three formulas”,with definite therapeutic effects;in terms of safety,real-world data shows that Xuebijing has relatively high safety;In terms of innovation,Xuebijing has clear pharmacological effects and clear pharmacokinetics;in terms of suitability,Xuebijing has clear clinical positioning and storage,but poor compliance;in terms of accessibility,Xuebijing ensures supply,has strong affordability for patients,and has strong production enterprise strength;in terms of inheritance,Xuebijing originates from classic and famous formulas,with prominent characteristics of traditional Chinese medicine;in terms of economy,although the daily average cost is relatively high,it brings pharmacoeconomic advantages by reducing patient mortality. [Conclusion] Xuebijing has good clinical value and the recommended level of Xuebijing Injection is “recommended”. |
|
|
|
|
|
|
|
